NSE › Healthcare

Cipla Limited (CIPLA)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,474.40+0.08%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹6,541 cr

Revenue YoY

-2.7%

Net profit

₹555 cr

Profit YoY

-54.6%

EPS

₹6.86

EPS estimate

₹9.67

Net margin

8.5%

EPS came in at 6.86 against a street estimate of 9.67 — a miss of 29.1%.

Key statistics

Market cap

₹1.20 lakh cr

P/E

35.5

Forward P/E

24.3

P/B

3.46

Book value

₹426.25

EPS (TTM)

₹41.69

52-week high

₹1,657.45

52-week low

₹1,154.87

50-day MA

₹1,418.92

200-day MA

₹1,395.50

Beta

0.11

Analyst view

with an average price target of ₹1,512.86.

Shareholding

Promoters

31.12%

Institutions

44.13%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cipla Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited

Data updated 2026-08-05.